Could a common sedative shield the brain after injury?
NCT ID NCT06661980
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether dexmedetomidine, a sedative drug, can protect the brain in people with brain injuries. Sixty patients were split into two groups: one received the drug, the other did not. Researchers measured consciousness levels and how long patients stayed in the ICU, along with certain brain-related biomarkers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN INJURIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Damanhour Teaching Hospital, General Organization for Teaching Hospitals and Institutes.
Damanhūr, Elbehairah, 31527, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Spinal zaps could reboot breathing after brain injury
- Could a 5-Day chill save brains after severe trauma?
- A handful of blueberries a day: a new weapon against cognitive decline?
- Brain wave test may reveal hidden thoughts in brain injury patients
- Hypnosis shows promise for brain injury memory recovery
- New procedure aims to help Brain-Injury patients breathe on their own